Ming Bioventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
1
- Investments
-
56
- Portfolio
-
39
- Exits
-
11
Ming Bioventures General Information
Company Description
Founded in 2018, Ming Bioventures is a venture capital firm based in Suzhou, China. The firm seeks to invest in life sciences, Innovative drugs, medical devices, and medical diagnostics sectors.
Business Details
Website
www.mingbioventures.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- Room 303, Building 6, Dongshahu Fund Town
- No.183 Suhong East Road, Suzhou Industrial Park
- Suzhou, Jiangsu
- China
Ming Bioventures Investments (56)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Mingcheng Biotechnology | 18-Mar-2026 | Early Stage VC | Biotechnology | Generating Revenue | ||
| Zenith Vascular | 25-Sep-2024 | Therapeutic Devices | Generating Revenue | |||
| Artheia (Suzhou) | 28-Jan-2024 | Therapeutic Devices | Generating Revenue | |||
| Enrocon Medical | 14-Dec-2023 | Surgical Devices | Generating Revenue | |||
| Innovo Therapeutics | 01-Dec-2023 | Drug Discovery | Generating Revenue | |||
| Pairui Biotechnology | 15-Sep-2023 | Biotechnology | Generating Revenue | |||
| Beyond Therapeutics | 29-Jun-2023 | Drug Discovery | Generating Revenue | |||
| Tyligand Bioscience | 28-Jun-2023 | Drug Discovery | Generating Revenue | |||
| Huiliao | 10-Mar-2023 | Early Stage VC | Pharmaceuticals | Generating Revenue | ||
| Innocardiac Medical | 18-Nov-2022 | Secondary Transaction - Private | Surgical Devices | Generating Revenue |
Ming Bioventures Exits (11)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Evopoint Biosciences | 16-Sep-2026 | IPO | |
| NuProbe | 17-Jun-2026 | ||
| EndoClot Plus | 27-Jan-2025 | ||
| Zion Pharma | 02-Aug-2024 | ||
| AbogenBio | 21-May-2021 | ||
| CMAB | 07-May-2021 | Merger/Acquisition | |
| Basecare | 08-Feb-2021 | IPO |
Ming Bioventures Investments by Industry, Year, and Region
Ming Bioventures Co-Investors (30)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Chase Capital Partners | 1 |
|
|
||
| China Medical System Holdings |
|
|
|||
| Huajin Investment |
|
|
|||
| Shunwei Capital |
|
|
|||
| Yonghua Capital |
|
|
Ming Bioventures FAQs
-
What is Ming Bioventures?
Founded in 2018, Ming Bioventures is a venture capital firm based in Suzhou, China.
-
When was Ming Bioventures founded?
Ming Bioventures was founded in 2018.
-
Where is Ming Bioventures headquartered?
Ming Bioventures is headquartered in Suzhou, China.
-
What is Ming Bioventures's total asset value?
Ming Bioventures has around in total assets under management.
-
How many investments has Ming Bioventures made?
Ming Bioventures has made 56 investments.
-
What has Ming Bioventures invested in?
Ming Bioventures has made numerous investments in companies like Mingcheng Biotechnology, Zenith Vascular, and Artheia (Suzhou) within the Biotechnology and Therapeutic Devices industries.
-
What has Ming Bioventures invested in recently?
Ming Bioventures's latest investment was on 18-Mar-2026 in Mingcheng Biotechnology, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process